To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

NCT04659070 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Hypertension

Interventions

DRUG: Experimental : Ezetimibe / Rosuvastatin + Telmisartan
DRUG: Active comparator1 : Ezetimibe / Rosuvastatin
DRUG: Active comparator2 : Telmisartan

Sponsor

Hanlim Pharm. Co., Ltd.